Watch CBS News

FDA approves weight loss drug Zepbound, joining Ozempic and Wegovy in market

The FDA has approved a new drug from Eli Lilly to help Americans lose weight: Zepbound. The drug is a new formula of the popular diabetes treatment Mounjaro and it joins other medications like Ozempic and Wegovy as weapons against obesity. Emergency medicine physician Dr. Owais Durrani joined CBS News to discuss the new drug and its potential side effects.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.